Blog

Aug 12, 2024, 22:14

Exercise reduces CIPN during Chemotherapy

Alessandro Samuelly, Medical oncologist at the University of Turin, shared on X:

“Great results from a very achievable training schedule to reduce CIPN, training while receiving chemotherapy with oxalipaltin and vinca alcaloids. Growing evidence supports exercise as a crucial element in cancer patient care.

‘Preventive Effect of Neuromuscular Training on Chemotherapy-Induced Neuropathy. A Randomized Clinical Trial‘

Authors: Fiona Streckmann, Thomas Elter, Helmar C. Lehmann, Hansjörg Baurecht, Tatjana Nazarenus, Vanessa Oschwald,Christina Koliamitra, Sarah Otten, Andreas Draube, Petra Heinen, Tilman Steinmetz, Michael Hallek, Michael Leitzmann, Wilhelm Bloch, Maryam Balke.”

Alessandro Samuelly

Source: Alessandro Samuelly/X

Alessandro Samuelly Andreas Draube cancer chemotherapy Christina Koliamitra Fiona Streckmann Hansjörg Baurecht Helmar C. Lehmann Maryam Balke Michael Hallek Michael Leitzmann OncoDaily Oncology Petra Heinen Sarah Otten Tatjana Nazarenus Thomas Elter Tilman Steinmetz Wilhelm Bloch

FDA approval: Pembrolizumab for HER2 positive gastric or GEJ adenocarcinoma expressing PD-L1 (CPS ≥1): KEYNOTE-811 Trial

Changing the Future of Adolescent and Young Adult Cancer Care

OncoDaily Launches New Social Channel on Telegram – @OncoDaily

In Memory of Chadwick Boseman and His Colon Cancer Battle

Groundbreaking Canadian Cancer Society-funded research aims to reshape the future of advanced cancer